Prana Biotechnology Limited
Records under this name other than the patents Prana Biotechnology Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Prana Biotechnology Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,357,770 | Method of treating immunoglobulin light chain amyloidosis Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,692,011 | 8-hydroxy and 8-mercapto quinazolinones Term ended Term ended Jun 7, 2026 · USPTO record | Term ended | Term ended Jun 7, 2026 | USPTO record |
| US 8,084,459 | Substituted quinazolinones for treating neurological conditions Term ended Term ended Jul 13, 2025 · USPTO record | Term ended | Term ended Jul 13, 2025 | USPTO record |
| US 11,008,319 | 4H-pyrido[1,2-a]pyrimidin-4-one compounds Lapsed on the fee record Ended May 18, 2025 · USPTO record | Lapsed on the fee record | Ended May 18, 2025 | USPTO record |
| US 10,738,050 | 4H-pyrido[1,2-A]pyrimidin-4-one compounds Lapsed on the fee record Ended Aug 11, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 11, 2024 | USPTO record |
| US 7,619,091 | 8-hydroxy quinoline derivatives Term ended Term ended May 22, 2024 · USPTO record | Term ended | Term ended May 22, 2024 | USPTO record |
| US 8,163,760 | Use of pyridopyrimidine compounds in the treatment of gliomas Lapsed on the fee record Ended Apr 24, 2024 · USPTO record | Lapsed on the fee record | Ended Apr 24, 2024 | USPTO record |
| US 9,163,018 | Method of treatment of age-related macular degeneration (AMD) Lapsed on the fee record Ended Oct 20, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 20, 2023 | USPTO record |
| US 9,169,211 | 8-hydroxy quinoline derivatives Term ended Ended no later than Jul 16, 2023 · USPTO record | Term ended | Ended no later than Jul 16, 2023 | USPTO record |
| US 9,302,993 | 8-hydroxy quinoline derivatives Term ended Ended no later than Jul 16, 2023 · USPTO record | Term ended | Ended no later than Jul 16, 2023 | USPTO record |